Drug intelligence / Profile preview

tetanus toxoid alum precipitated

Development stage
Unknown
Lead developer
Adimmune
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Tetanus toxoid alum precipitated is a vaccine formulation designed to provide active immunity against tetanus, a serious disease caused by the toxin-producing bacterium *Clostridium tetani*. The vaccine contains tetanus toxoid—a chemically inactivated form of the tetanus toxin—which is adsorbed onto an aluminum-based adjuvant (alum) to enhance the immune response and prolong the duration of protection. Upon administration, the vaccine stimulates the production of specific antitoxin antibodies that neutralize the tetanus toxin, thereby preventing the clinical manifestations of the disease. Adimmune (formerly Kuo Kwang Biotechnology) is developing this specific alum-precipitated formulation, which is currently in the registration phase (NDA/BLA) for the prevention of tetanus.

Brand names
Kuo Kwang
Other names
tetanus toxoid alum precipitatedtetanus toxoid adsorbedadsorbed tetanus toxoidtetanus vaccine
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TT-Al (Tetanus toxoid-adsorbed aluminum adjuvant)

Beyond the preview

Go deeper on tetanus toxoid alum precipitated.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetanus toxoid alum precipitated.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call